LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 47.59 | 21.74 | 1207 | 4492 | 0.2687 | 0.6859 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 47.59 | 21.74 | 1221 | 4492 | 0.2718 | 0.6884 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 47.59 | 21.74 | 1208 | 4492 | 0.2689 | 0.6860 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 47.59 | 21.74 | 1219 | 4492 | 0.2714 | 0.6880 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 49.56 | 21.74 | 1228 | 4838 | 0.2538 | 0.6775 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 49.56 | 21.74 | 1239 | 4838 | 0.2561 | 0.6794 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 49.56 | 21.74 | 1203 | 4838 | 0.2486 | 0.6731 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 49.56 | 21.74 | 1215 | 4838 | 0.2511 | 0.6752 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 51.53 | 21.74 | 1236 | 5150 | 0.2400 | 0.6690 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 51.53 | 21.74 | 1245 | 5150 | 0.2417 | 0.6705 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 51.53 | 21.74 | 1198 | 5150 | 0.2326 | 0.6624 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 51.53 | 21.74 | 1214 | 5150 | 0.2357 | 0.6652 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 53.50 | 21.74 | 1231 | 5425 | 0.2269 | 0.6601 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 53.50 | 21.74 | 1243 | 5425 | 0.2291 | 0.6621 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 53.50 | 21.74 | 1219 | 5425 | 0.2247 | 0.6581 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 53.50 | 21.74 | 1236 | 5425 | 0.2278 | 0.6609 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 55.48 | 21.74 | 1254 | 5768 | 0.2174 | 0.6547 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 55.48 | 21.74 | 1271 | 5768 | 0.2203 | 0.6575 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 55.48 | 21.74 | 1207 | 5768 | 0.2092 | 0.6469 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 55.48 | 21.74 | 1225 | 5768 | 0.2124 | 0.6499 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 57.45 | 21.74 | 1244 | 6023 | 0.2065 | 0.6467 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 57.45 | 21.74 | 1256 | 6023 | 0.2085 | 0.6486 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 57.45 | 21.74 | 1220 | 6023 | 0.2025 | 0.6427 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 57.45 | 21.74 | 1234 | 6023 | 0.2049 | 0.6450 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 59.42 | 21.74 | 1242 | 6125 | 0.2028 | 0.6439 | MN20160310_N01 | L03 |